Connect with us

Legal & Regulation

Arizona’s Medical Marijuana Program to Start Testing Cannabis Products and Companies in New Bill



Arizona’s Medical Marijuana Program to Start Testing Cannabis Products and Companies in New Bill

In early June, Governor, Doug Ducey supposedly signed the Senate Bill 1494, which requires “registered non-profit medical marijuana dispensaries” to test cannabis for potential toxins reports Cannabis Business Times.

As per the claims made, the bill enforces a 12-member committee, in which members with various roles belonging to the cannabis industry will be handpicked by the director of the Department of Health Services (DHS).

The law is believed to come into effect after November 1, 2020. This means that any medical marijuana product sold after this date will have to undergo the necessary testing for the overall potency of said solution as well as the possible presence of solvents, pesticides and heavy metals among others.

According to the Political Director of the Marijuana Policy Project (MPP),

“Patients need and deserve to know what is in the product they are consuming. The goal of the program is to help people with debilitating health conditions.”

All this being said, here’s what consumers and businesses need to know:

How Should Testing be Dealt With and Perceived?

Cannabis businesses have been advised to perform internal testing to avoid consequences that arise from toxins. Internal testing implies testing the overall cleanliness of the facilities used, as well as the growing and processing procedures.

AJ Montgomery, Head of Marketing for cannabis brand, Huxton, hopes businesses will be reactive to this decision, as the latter is necessary to ensure that the industry is evolving in the right direction. He further notes that this bill ensures that more businesses will be transparent about their products. This is an important facet as not all medical marijuana is created equally.

Changes to Medical Marijuana Consumption

In addition to how testing should be dealt and perceived, the following changes will be made in relation to said uses:

  • Medical marijuana patients to renew their state-issued cards every 2 years versus yearly
  • The annual $150 fee for card renewal will now be a biannual fee
  • Rural populations will be prioritized when issuing dispensary licenses
  • DHS is given the authority to conduct inspections of licensed cannabis businesses and are allowed to take action accordingly
  • Possible removal of restricted quantity of cannabis purchased
  • Possible involvement of doctors in deciding which health conditions most require medical marijuana

What are your thoughts on the Senate Bill 1494? Do you think Arizona’s approach in flourishing the medical marijuana market is spot on? Let us know in the comments below.

Mandi brings an uplifting presence with universal experience to the COR team by hosting an honorable 11-year track record of elbow-greased content writing while adding in 20 years of expertise in business administration. This unique combination of wit and will is exactly what makes this site and all of our valued readers so special.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.